Insider Transactions in Q4 2024 at Phreesia, Inc. (PHR)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 31
2024
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
546
+1.47%
|
$9,828
$18.29 P/Share
|
Oct 31
2024
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
546
+1.15%
|
$9,828
$18.29 P/Share
|
Oct 31
2024
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
546
+1.31%
|
$9,828
$18.29 P/Share
|
Oct 18
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
1,100
-0.55%
|
$22,000
$20.49 P/Share
|
Oct 16
2024
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
423
-1.55%
|
$8,883
$21.33 P/Share
|
Oct 15
2024
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
864
-0.88%
|
$18,144
$21.03 P/Share
|
Oct 15
2024
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
1,212
-1.0%
|
$25,452
$21.03 P/Share
|
Oct 15
2024
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,843
-0.24%
|
$38,703
$21.03 P/Share
|
Oct 15
2024
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
2,011
-0.99%
|
$42,231
$21.03 P/Share
|
Oct 15
2024
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,089
-0.25%
|
$64,869
$21.03 P/Share
|
Oct 15
2024
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,791
-4.69%
|
$55,820
$20.97 P/Share
|
Oct 15
2024
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
624
-0.52%
|
$13,104
$21.03 P/Share
|